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1. Introduction 2. Structural homology between gas&in and middle T 
protein 
Gastrin and the transforming protein (middle T 
antigen) of polyoma virus are superficially dissimilar 
molecules. However, this paper notes a hitherto un- 
reported structural relationship between the 2 proteins 
which supports the hypothesis that they have evolved 
from a common ancestor. 
Gastrln [l] is best known for its stimulation of 
acid secretion by the stomach epithelium, and of 
enzyme secretion by the stomach and pancreas [2]. 
More recently, the hormone has been shown to stim- 
ulate cellular proliferation both in vivo and in vitro 
[3-51. Several overlapping forms which vary in length 
from 14-34 amino acids have been isolated [2]. It 
seems probable that all of these fragments are pro- 
duced by proteolysis of a much larger prohormone, 
since the mRNA for pig gastrin is -620 nucleotides 
long [6]. While the common C-terminal tetrapeptide 
amide Trp-Met-Asp-Phe-NH2 elicits all the effects 
of the larger molecules, biological potency increases 
almost 2 orders of magnitude with increasing chain 
length, and is maximal for gastrin 9 (numbering from 
the C-terminal) [7]. 
Human gastrin is structurally homologous to a 
region of middle T protein of polyoma virus -100 
residues from its C-terminus. Homology is especially 
apparent around the sole tyrosine residue of gastrin, 
where 8 of 11 amino acids are identical (fig.1). With 
one gap inserted in the gastrin sequence the position 
of 14 amino acids in 34 (41%) is identical. Since poly- 
oma virus infects rodents only, sequence homology 
with rodent rather than human gastrin may be even 
stronger. 
Polyoma virus is able to produce a wide range of 
tumours in rodents [8]. The early region of the poly- 
oma virus genome codes for 3 proteins: small T 
(M, 23 000), middle T (M, 50 000) and large T 
(M, 88 000) antigens [9]. The small T and large T 
proteins are not required for transformation [lo], but 
mutational alteration of middle T protein causes 
changes in transformation frequency [ 1 l-l 61. The 
dramatic reductions caused by mutations near the 
presumed membrane binding site [ 141 suggest hat 
membrane attachment of middle T protein [ 171 is 
essential for transformation. 
Statistical comparison of the sequence shown in 
fig.1 by the method in [26] (table 1) provided un- 
equivocal evidence of an evolutionary relationship 
between the C-terminal 17 amino acids of gastrin and 
middle T protein. The probability of relationship 
between the N-terminal 17 amino acids of gastrin and 
middle T protein was considerably lower. (The gastrin 
sequence was compared in 2 sections because it was 
necessary to insert a gap after residue 17 to maximize 
homology.) However, the similarity in the number 
and position of proline residues in the N-terminal 
gastrin segment and middle T protein suggests that 
the conformational restraints imposed by this unusual 
amino acid may produce a greater similarity in ter- 
tiary structure than is indicated by the statistical 
sequence analysis. A control comparison of gastrin 
with the oncoproteins of Rous and Moloney sarcoma 
viruses did not detect any significant homology in the 
region of the modified tyrosine (table 1). 
Similarities have been reported in the arrangement 
of 2 clusters of cysteine residues (Cys-X-Cys-X-X- 
Cys) in the common region of the polyoma small and 
middle T proteins, and in the (Y and /3 subunits of 
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Table 1 
Statistical comparison of the amino acid sequences of gastrin 
and viral oncoproteins [probability that alignment is a 
random occurrence (%)] 
Gastrin Polyoma RSV MSV 
N-terminal 17 residues 10-50 SO-95 95 
C-terminal 17 residues O.Ol- 0.01 SO-95 50-95 
Entire molecule 0.1 SO-95 95 
The alignments hown in tig.1 were compared by the method 
in [ 261. Comparison of the uninterrupted gastrin sequence 
with the polyoma oncoprotein gave probability values of 
50-95% for the N-terminal 17 residues, and 1% for the entire 
molecule 
GASTRIN 0 
POLYOMA 0 
;:; tj$ i%i 1; 7; 
- G R 
MUTANT dl 23 
Fig.1. Comparison of the amino acid sequence of gastrin with polyoma middle T protein and other oncoproteins. The amino acid 
sequences of human gas&in [ 18,191, polyoma middle T protein [20,21], and the oncoproteins of Maloney [22] and Rous [23] 
sarcoma viruses (MSV and RSV, respectively) were aligned about their modified tyrosine residues, with one gap inserted in the 
gastrin sequence to maximize homology (see table 1). The C-terminus of gastrin is amidated [ 191. Polyoma mutant d145 has 22 
amino acids deleted, but transforms normally [ 121. Polyoma mutant d123 has 34 amino acids deleted [ 241, transforms less efti- 
ciently than wild-type virus [ 111 (mean plating efficiency f SEM: dl23,lO.g f 11.1; wild-type, 65.7 + 4.1 [ 131) and has a con- 
siderably reduced protein kinase activity [ 251. The one letter code for amino acids is: A, alanine; C, cysteine; D, aspartic acid; E, 
glutamic acid; F, phenylalanine; G, glycine; H, histidine; I, isoleucine; K, lysine; L, leucine; M, methionine; N, asparagine; P, 
proline; Q, glutamine; R, arginine; S, serine; T, threonine; V, valine; W, tryptophan; Y, tyrosine; @ modified tyrosine; Z, pyro- 
glutamic acid. Amino acids identical to those in gastrin are enclosed in boxes. Arrows represent continuation of sequence, and 
deletions are underlined. 
follitropin, lutropin, thyrotropin and chorionic gonado- 
tropin [27,28]. However it seems improbable that there 
is any functional similarity between middle T protein 
and the hormones, since the same arrangement of 
cysteines is also found in two immunoglobulin y chains, 
in one class of keratin, and in metallothionein [27,29]. 
Presumably the complete loss of transforming ability 
associated with deletion of both clusters in the poly- 
oma host-range transformation mutant NG 18 [30] 
is only a reflection of the importance of disulphide 
bond formation by the cysteines in the maintenance 
of the active conformation of the protein. 
The tyrosine residue is sulphated in -l/2 of gastrin 
molecules [31]. The corresponding tyrosine residue 
of the middle T protein is phosphorylated by an asso- 
ciated protein kinase activity [32-341. Since sulpho- 
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and phosphotyrosine are very similar in structure, the 
sequence homology between gastrin and polyoma 
virus middle T protein extends to homologous modi- 
fication of a conserved tyrosine residue. 
3. Origin of homology 
The structural homology described in section 2 
could have arisen by either convergent or divergent 
evolution. Thus 2 unrelated proteins may have inde- 
pendently converged to a similar sequence capable 
of recognition by related tyrosine sulpho- and phos- 
phokinases. The preponderance of acidic amino acids 
on the N-terminal side of the modified tyrosines of 
gastrin, middle T protein, and the oncoprotein of 
Rous sarcoma virus may well represent such a recog- 
nition site. However, the fact that further homology 
is apparent only between gastrin and middle T pro- 
tein strongly suggests hat in this case the sequences 
have not arisen by convergent evolution. Similar argu- 
ments may be raised against the suggestion that the 
two proteins have independently evolved a polyglu- 
tamic acid sequence as a metal ion-binding site [35]. 
Alternatively the 2 proteins may have diverged 
from a common ancestor, in which case some vestigial 
functional similarities would be expected. Indeed the 
2 proteins hare the ability to promote cellular prolifer- 
ation. Excessive production of gastrin in vivo by 
Zollinger-Ellison tumours is associated with hyper- 
plasia of the fundic mucosa [36]. Conversely, reduc- 
tion in gastrin levels following antrectomy results in 
parietal cell atrophy [37,38]. Both gastrin 17 and 
gastrin 34 have been shown to stimulate DNA syn- 
thesis in rat intestinal mucosa [39]. There may also 
be a connection between the increased incidence of 
gastric arcinoma [40] and the elevated serum gastrin 
levels [41] observed in patients with pernicious 
anaemia. Increased stem cell proliferation in the 
atrophic gastric mucosa in response to gastrin would 
be expected to increase DNA synthesis and thus the 
frequency of spontaneous neoplastic mutation. Viral 
transformation isof course accompanied by unre- 
strained cellular proliferation. The transforming func- 
tion of middle T protein is inferred primarily from 
the transforming ability of the plasmid pEyMT1, which 
encodes only the middle T protein [lo], and from 
deletion mutants uch as d123 (fig.l), in which loss 
of a DNA sequence in the region coding for the con- 
served tyrosine residue results-in areduction in the 
efficiency of transformation [ 11,241. Tumour forma- 
tion in vivo occurs in a number of tissues including 
gastric epithelium, with the parotid gland as the 
favoured site [8]. This distribution may simply reflect 
differences in viral attachment to celI membranes 
rather than differences in the transformation frequency 
of infected cells in the various tissues. Thus the abil- 
ity of both proteins to promote cellular proliferation 
appears to favour divergent evolution as the origin of 
the observed sequence homology. 
A similar evolutionary relationship may well exist 
between epidermal growth factor (EGF) and the trans- 
forming growth factors (TGF) isolated from cells 
transformed by Moloney sarcoma virus [42] or by 
chemicals [43]. The observation that TGF binds to 
EGF receptors but not to EGF antibodies uggests 
limited structural homology [42]. However, com- 
parison of the nucleotide sequence of the Moloney 
sarcoma virus oncogene [22] with the amino acid 
sequence of EGF [44] does not reveal any obvious 
similarities. 
4. Mechanisms of transformation by polyoma virus 
The fact that the DNA coding for the region of the 
polyoma middle T protein surrounding phospho- 
tyrosine is not present in the related SV40 genome 
[20,21], suggests hat polyoma virus may have evolved 
from an SV40-like virus by incorporation of rodent 
DNA sequences into its genome. Moreover, the 
sequence homology between gastrin and a region of 
the middle T protein suggests hat the sequences 
included the rodent gastrin gene. Acquisition of the 
gastrin sequence would be expected to confer a sig- 
nificant selective advantage on the virus, since the 
trophic effects of the hormone would ensure a con- 
tinual increase in the nwrnber of cells available for 
virus multiplication. Since middle T protein is mem- 
brane-bound [ 171 (and presumably intracellular in 
the intact cell), and since cell lysis is no longer equired 
for viral transfer to unsaturated cells, both protein 
and virus would thus escape the animal’s immune sys- 
tem. This mechanism issimilar to that proposed in 
[45] for viral leukemogenesis, in which interaction of 
viral envelope antigens with surface receptors of 
infectedlymphocytes ‘stimulates the T cell to undergo 
continued rounds of antigen-induced proliferation’. 
However, several observations suggest that such a sim- 
ple scheme, involving only the region of middle T pro- 
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tein homologous to gastrin, cannot be the only mech- 
anism for papova virus transformation: 
0) 
(ii) 
_ _ 
The SV40 genome, whichlacks the region homol- 
ogous to the gastrin gene [20,21], can still trans- 
form cells efficiently; 
The polyoma deletion mutant d123 which lacks 
most of the region of middle T protein homol- 
ogous to gas&in can still transform cells; though 
with reduced efficiency compared to wild-type 
virus ([ 11,241, fig.1); 
(iii) The plasmld pPyMT1, which encodes the middle 
T protein, but not the small T and large T pro- 
teins, is only 20-45% as efficient in transforma- 
tion as the control plasmid containing the entire 
polyoma genome [lo]. 
Thus polyoma virus appears to have evolved altema- 
tive transformation mechanisms [ 161. 
The role of tyrosine modification in the transfor- 
mation process is not clear. In the case of middle T 
protein some mutations which alter transformation 
frequency also alter the level of the associated protein 
kinase activity [25]. Although sulphation of tyrosine 
does not appear to alter the effectiveness of gastrin in 
stimulating either acid secretion [46] or DNA synthe- 
sis in rat intestinal mucosa [39], these results do not 
exclude the possibility that sulphate could be attached 
to, or removed from, the gastrin molecule within the 
target cell. However, the synthetic analogue penta- 
gastrin [47], which has the structure T-butoxycar- 
bonyl+Ala-Trp-Met-Asp-Phe-CO-NH2, can 
elicit all the trophic effects of the parent molecule 
[3-51 (albeit at a significantly higher concentration 
[ 391) even though it lacks the tyrosine residue. Further 
evidence that phosphotyrosine may not play an essen- 
tial role in all transformation mechanisms comes from 
a comparison of the nucleotide sequences of the onco- 
genes of Moloney [22] and Rous [23] sarcoma 
viruses. Despite xtensive homology the former 
sequence lacks the codon specifying the tyrosine 
residue whose autophosphorylation correlates with 
transformation [32,48]. 
5. Future experiments 
The hypothesis that gastrin and the middle T pro- 
tein of polyoma virus have evolved from a common 
ancestor suggests a number of experiments. In partic- 
ular the mechanistic role of the modified tyrosine 
residue can be tested directly by insertion of poly- 
nucleotides coding for the C-terminal tetrapeptide of
gastrin, and various extensions of it, into the appro- 
priate region of the deletion mutant d123 genome to 
study their effects on transformation. The hypothesis 
is also consistent with the more general idea [49] that 
the viral oncoproteins responsible for tumorigenesis 
[10,50] have structurally homologous counterparts in
uninfected cells [51,52], and that these ‘cellular onco- 
proteins’ are the growth regulators which control 
the proliferation of normal cells. Comparison of viral 
oncoprotein sequences with those of growth regulators 
like epidermal growth factor [44], nerve growth factor 
[53] and granulocyte-macrophage colony-stimulating 
factor [54] may therefore uncover further unexpected 
similarities. 
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